Author: Margaret Patrick

Margaret Patrick has been writing for Market Realist since 2014. She covers hospital, health insurance, biotech, pharmaceutical, and medical device stocks.

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

The Cannabis 2.0 era has officially started. Now, Canadians can legally access a host of cannabis-infused products like beverages, vapes, and edibles.

Yesterday, HEXO (HEXO) announced the launch of a lower-priced cannabis brand, Original Stash, priced at $4.49 per gram.

On Wednesday, Aurora Cannabis gave a preview of its Cannabis 2.0 strategy. The company provided plans for the roll-out of edibles, concentrates, and vapes.

On October 15, Canopy Growth (CGC) completed the acquisition of cannabinoid-based research company Beckley Canopy Therapeutics.

On October 15, Aphria (APHA) reported its earnings results for the first quarter of fiscal 2020, which ended on August 31.

Today CannTrust Holdings is trading at $1.30 on the NYSE, 25.60% higher than its last closing price. It's risen even faster on the Toronto Stock Exchange.

Mexico is fast approaching its October 23 marijuana legalization deadline. Multiple legalization proposals before parliament are creating confusion.

Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

Hexo Corp. (HEXO) stock is down 26.24% on the NYSE on a year-to-date basis. This cannabis company has lost 33.94% of its value since October 1.

Colorado reported $1.16 billion in marijuana sales in the first eight months of 2019. In 2018, the state reported marijuana sales of $1.54 billion.